Institute of Biomedical Research Corp
Institute of Biomedical Research Corp. provides biomedical research and analytical services in Montenegro and internationally. Its services include regulatory control of industrial activities and products; scientific surveillance of the living environment; research and development of biomedical products and technologies; regulatory evaluation and certification of biomedical products; fundamental … Read more
Market Cap & Net Worth: Institute of Biomedical Research Corp (MRES)
Institute of Biomedical Research Corp (PINK:MRES) has a market capitalization of $38.40 Million ($38.40 Million) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #49944 globally and #15247 in its home market, demonstrating a 23.48% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Institute of Biomedical Research Corp's stock price $0.01 by its total outstanding shares 2704487420 (2.70 Billion).
Institute of Biomedical Research Corp Market Cap History: 2015 to 2025
Institute of Biomedical Research Corp's market capitalization history from 2015 to 2025. Data shows growth from $4.06 Million to $38.40 Million (21.20% CAGR).
Institute of Biomedical Research Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Institute of Biomedical Research Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
776.04x
Institute of Biomedical Research Corp's market cap is 776.04 times its annual revenue
1728.56x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $4.06 Million | $1.41 Million | $564.67K | 2.88x | 7.18x |
| 2023 | $22.99 Million | $29.44K | -$433.41K | 780.74x | N/A |
| 2024 | $25.69 Million | $45.07K | $1.33 Million | 570.01x | 19.32x |
| 2025 | $38.40 Million | $49.49K | -$632.72K | 776.04x | N/A |
Competitor Companies of MRES by Market Capitalization
Companies near Institute of Biomedical Research Corp in the global market cap rankings as of March 19, 2026.
Key companies related to Institute of Biomedical Research Corp by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Institute of Biomedical Research Corp Historical Marketcap From 2015 to 2025
Between 2015 and today, Institute of Biomedical Research Corp's market cap moved from $4.06 Million to $ 38.40 Million, with a yearly change of 21.20%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $38.40 Million | +49.47% |
| 2024 | $25.69 Million | +11.76% |
| 2023 | $22.99 Million | -50.00% |
| 2022 | $45.98 Million | +126.67% |
| 2021 | $20.28 Million | +971.43% |
| 2020 | $1.89 Million | +75.00% |
| 2019 | $1.08 Million | -42.86% |
| 2018 | $1.89 Million | +40.00% |
| 2017 | $1.35 Million | +150.00% |
| 2016 | $540.90K | -86.67% |
| 2015 | $4.06 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Institute of Biomedical Research Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $38.40 Million USD |
| MoneyControl | $38.40 Million USD |
| MarketWatch | $38.40 Million USD |
| marketcap.company | $38.40 Million USD |
| Reuters | $38.40 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.